Clinical Study

Effect of a Selective Progesterone Receptor Modulator on Induction of Apoptosis in Uterine Fibroids In Vivo

Table 2

Apoptotic index (AI) in the subgroups of the study.

Type of preoperative treatmentNumber of patientsMean AI (±SD)Median of AIRange of AINumber of patients with
AI > 10

SPRM11158.9 (±193.2)960–6729 (81.8%)
GnRHa1727.5 (±62.3)20–1964 (23.5%)
No treatment102.0 (±2.1)10–60

AI: apoptotic index, GnRHa: gonadoliberin agonist, and SPRM: selective progesterone receptor modulator.